Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00734200 in adults with type 2 diabetes mellitus on stable metformin
2007-001922-28Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing PF-00734200 + metformin with Placebo + metformin (2 arms). Primary endpoints: Safety and tolerability of PF-00734200 and Change in HbA1c from baseline to Week 12. Started Jun 2007; status: completed.
02
Drugs
gosogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-001922-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001922-28.